NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

Remdesivir in pregnant women with moderate to severe coronavirus

COVID-19 critical illness in pregnancy - Stephen E Lapinsky, Maha

Management of moderate severity outpatients with COVID‐19 disease

NIH Coronavirus Funding

SARS-CoV-2 Infection and COVID-19 During Pregnancy: A

Outpatient Treatment Options for Acute COVID-19 ​

Evaluation & Management of COVID-19 in Pregnancy

Covid-19 Research Opens to Little-Studied Group: Pregnant Patients

Baricitinib in Combination with Remdesivir Reduces Time to

Federal Response to COVID-19: Therapeutics CIG